Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Claudin-2 is a 230-amino acid, tetraspan transmembrane protein that forms the backbone of tight junction strands in leaky epithelial tissues. Its extracellular domains line selective paracellular pores through which small cations and water can cross, contributing to energy-efficient transport especially in the kidney proximal tubule and intestinal tract. Regulation of Claudin-2 expression and phosphorylation affects its localization, permeability, and turnover; altered expression is linked to pathological states such as cancer progression, inflammatory disease, and kidney dysfunction. Beyond simply controlling epithelial permeability, Claudin-2 participates in signaling networks that modulate cell proliferation and fate, making it a multifaceted therapeutic target.
Modulation of tight-junction permeability by altering Claudin-2 channel gating or expression; Inhibition or blockade of Claudin-2 to regulate ion flux and tissue barrier properties.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Claudin-2 (CLDN2).